AD is a progressive neurodegenerative disorder characterized by key pathological hallmarks, including synaptic dysfunction due to tau protein hyperphosphorylation, reduced neuronal metabolism, and the loss of multiple neurotransmitters such as acetylcholine, noradrenaline, serotonin, and dopamine. The gene discussed is MAPT; the disease is Alzheimer disease.